Clinical Trial Update: S-Equol in Alzheimer's Disease (SEAD) Trial [Phase 1]

View source ↗

Summary

This update notes the completion of the Phase 1 SEAD trial evaluating S-Equol for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• S-Equol (S-equol)

Snippet

Sponsor: Russell Swerdlow, MD | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED